COVID-19疫苗接紀卡OVID9Vcini
中文姓名
觸咪
英文姓名(同護照)
True
Name
Last Name
出生日期(西元)
國籍
身分證/居留證/護照號碼
Date of Birth
mm
dd
Nationality
ID/ARC/passport No.
疫苗種類/劑次
廠牌/品名
接種日期
Date vaccine given
醫師或接種者簽名
Vaccine/ Dose
Manufacturer/
Signature of
Product name
yyyy / mm/ dd
healthcare professional
COVID-19疫苗第1劑
COVID-19 1* dose
AstraZeneca
2021/9/10
第2劑預約日期A
COVID-19疫苗第2劑
AstraZeneca
2021/11/22
COVID-19 2" dose
Covid-19
Moderna
2022/4 /18
疫苗第三劑
Covid-19
疫苗第四劑
Covid-19
疫苗第五劑
Covid-19
疫苗第六劑
mll
First Name
yyyy
接種單位章戳
Official stamp of
administering center
こににこににこににここにこ
Covid-19
疫苗第一百劑
我要查核闢謠 被回報 2 次|1,168 天前
許多完全接種了covid疫苗的人現在都失明了
我們聽說了很多關於注射後心肌炎和心包炎的案例,以及接受者即使在註射後仍反複檢測出病毒“陽性”。但是,武漢冠狀病毒(COVID-19)的“完全接種疫苗”中還有另一個很少被提及的副作用:失明。
英國的最新數據表明,越來越多的人正在失去視力。藥品和保健品監管機構 (MHRA) 黃卡系統目前顯示,在被輝瑞-BioNTech 針刺傷的人群中,有 163 例完全失明,另外還有 6 例中心視力喪失和 4 例突然視力喪失。
據報導,現在還有 21 人患有由輝瑞注射液特別引起的“暫時性失明”。這種不良反應包括一次視覺障礙或一隻眼睛失明幾秒鐘甚至幾分鐘。
據報導,除此之外還有 20 人患有稱為“單側失明”的反應,即一個人僅一隻眼睛失明或視力模糊。
“截至 2022 年 4 月 6 日,總共有 8,016 例眼部疾病被報告為對輝瑞 (Pfizer) 疫苗的不良反應,”《每日曝光》報導。
僅僅為了感覺“受到保護”免於感冒而失明是否值得?
阿斯利康(AstraZeneca)注射劑是目前英國可用的 COVID 刺針之一,它也與失明病例有關。
截至 4 月 6 日,MHRA 已收到 324 例失明報告,3 例中心視力喪失報告,5 例突發視力喪失報告,以及 14,895 例眼部疾病中的 29 例短暫失明報告,所有這些都與阿斯利康針頭有關。
Moderna 還在英國對人們進行了刺激,儘管速度比上述公司小得多。儘管如此,許多服用 Moderna 針的人現在也失明了。
MHRA 顯示,與 Moderna 注射劑一起,已有 34 例失明報告和 56 例視力障礙報告。總共有 1,519 例眼部疾病被報告為對 Moderna 刺拳的不良反應。
“總的來說,當包括未指定疫苗品牌的不良反應時,有 24,516 種眼部疾病報告為對 Covid-19 注射劑的不良反應,其中 525 種反應是完全失明,”Expose 報導。
“‘事實核查人員’與當局一道,一直在調查這些數據,並將其標記為不可靠。他們的理由是,‘僅僅因為有人在接種疫苗後報告了這一事件,並不一定意味著它是由於疫苗造成的。’”
一位名叫路易斯的人在推特上記錄了他妻子的故事,她在接受阿斯利康 (AstraZeneca) 刺戳後的幾周和幾個月內,左眼完全失明,右眼失明 30-60%。
治療這名婦女的神經科醫生警告她不要注射第二劑。
“正如你所看到的那樣,事實核查人員無視‘不一定是疫苗的錯’而忽視的痛苦,對於報告他們的人來說是非常真實的,”Exposé 補充道。
“但為什麼 COVID 疫苗會導致人們失明呢?”
答案可能與 COVID 疫苗也會引起包括中風在內的主要心血管問題有關。視力喪失通常伴隨著中風,所以這一切都開始變得有意義了。
加入並分享👉@NaturalNewsMedia
Many people fully vaccinated for covid are now going BLIND
We have heard all about the many cases of myocarditis and pericarditis post-injection, as well as recipients repeatedly testing “positive” for the virus even after doing the deed. But there is another concerning side effect occurring in the “fully vaccinated” for the Wuhan coronavirus (COVID-19) that is rarely mentioned: blindness.
The latest data out of the United Kingdom suggests that a growing number of fully jabbed people are losing their eyesight. The Medicines and Healthcare products Regulatory Agency (MHRA) Yellow Card system currently shows 163 cases of total blindness among people who got jabbed with the Pfizer-BioNTech needle, along with an additional six cases of central vision loss and four cases of sudden visual loss.
Twenty-one people also reportedly now suffer from “blindness transient” specifically caused by the Pfizer injection. This adverse reaction involves visual disturbance or loss of sight in one eye for a few seconds or even minutes at a time.
Another 20 people beyond that are reported to have suffered from a reaction called “unilateral blindness,” which is when a person got blind or blurred vision in just one eye.
“In total, there have been 8,016 eye disorders reported as adverse reactions to the Pfizer jab as of 6th April 2022,” reported the Daily Exposé.
Is it worth possibly going blind just to feel “protected” against a cold?
The AstraZeneca injection, which is one of the COVID jabs currently available in the U.K., is also linked to cases of blindness.
As of April 6, the MHRA has received 324 reports of blindness, three reports of central vision loss, five reports of sudden visual loss, and 29 reports of blindness transient among 14,895 eye disorders, all specifically linked to the AstraZeneca needle.
Moderna also jabs people in the UK, though at a much smaller rate than the aforementioned companies. Still, many people who take the Moderna needle are now blind as well.
The MHRA shows that in conjunction with the Moderna injection, there have been 34 reports of blindness and 56 reports of visual impairment. In total, there have been 1,519 eye disorders reported as adverse reactions to the Moderna jab.
“In all, when including adverse reactions reported where the brand of vaccine was not specified, there have been 24,516 eye disorders reported as adverse reactions to the Covid-19 injections, with 525 of these reactions being complete blindness,” the Exposé reported.
“‘Fact-checkers’ alongside authorities have been on the case to sweep this data under the carpet and have labelled it as unreliable. Their reasoning is that ‘just because someone reports the event after having the vaccine, it doesn’t necessarily mean it is due to the vaccine.'”
One person who goes by the name of Louis documented on Twitter the story of his wife, who in the weeks and months following her AstraZeneca jab went completely blind in her left eye and between 30-60 percent blind in her right eye.
The neurologist who treated the woman warned her not to get the second dose of the shot.
“As you can see the misery which the fact checkers are disregarding as ‘not necessarily the fault of the vaccine’ is very real for the people who are reporting them,” the Exposé added.
“But why are the COVID vaccines causing people to go blind?”
The answer could have to do with the fact that COVID vaccines also cause major cardiovascular problems, including stroke. Visual loss often accompanies stroke, so it is all starting to make sense.
Join and share 👉@NaturalNewsMedia 被回報 3 次|1 份回應 |860 天前
被回報 1 次|654 天前
(-)(-)(-)(-)(-)(-)(-)(-)美國黑水公司與蔡政府聯合
拿台灣當人體實驗室
台灣人,你還要忍多久?
(路透社2021-06-04 獨家報導 全文中英對照稿)
(-)(-)(-)(-)(-)(-)(-)(-)
(根據維基百科:路透社乃出生於德國的保羅路透(Paul Reuters)於1851年時在倫敦創辦,歷史悠久,旗下有2500名記者及600名攝影記者,從全球200多個社址發出報導,是全球最大、也是最有公信力的跨國媒體機構之一)
(以下中英文逐段並列翻譯,6分鐘內可讀完, 英文連結列在最後)
WASHINGTON, June 4 (Reuters) - Erik Prince, the founder of controversial private military firm Blackwater and a supporter of former President Donald Trump, jumped into the COVID-19 business late last year with a deal to distribute an experimental vaccine should it be approved, according to three people familiar with the arrangement and business records seen by Reuters.
路透社2021年6月4日華盛頓報導 — 普林斯(Erik Prince)是頗具爭議性的私人軍火公司「黑水」的創辦人,也是美國前總統川普的擁護者。根據路透社訪問過,熟悉黑水公司運作與交易紀錄的三位人士,普林斯從去年下半年起,也躍入新冠疫苗的商圈,企圖掌握一支目前尚在實驗階段的疫苗,以便未來若取得認證後,得以擁有銷售權。
The COVID-19 vaccine, known as UB-612, is being developed by a privately-held U.S. firm called COVAXX.
那支被稱為UB-612的新冠肺炎疫苗,乃是一家美國私人企業COVAXX所開發的。(譯者註:也就是聯亞生技所開發的聯亞疫苗)
The company has said the vaccine shows promise in protecting people against coronavirus, based on a small study of 60 patients in Taiwan. It hasn't provided data on safety and efficacy from large clinical trials, information that is usually required before a vaccine is authorized for public use.
該公司宣稱已在台灣60位病人中進行過小型實驗,顯示該疫苗可望保護病人對抗新冠肺炎,但尚未提供任何大型臨床實驗所得到,關於安全性及效能方面的數據,而那通常是疫苗可被認證供民眾施打前的必要條件。
COVAXX is unrelated to the similar-sounding but better-known "COVAX," a global vaccine distribution program backed by the World Health Organization.
以上所提到的這支COVAXX 疫苗,與另一支國際衛生組織(WHO)早已認證,也較知名的COVAX疫苗,聽起來頗相像,但成分截然不同,請勿混淆。
Since the start of the pandemic in 2020, the COVAXX vaccine has attracted some big-name backers, including endorsements from entrepreneur Peter Diamandis, who co-founded the company, and motivational speaker Tony Robbins. In March, the company raised $1.35 billion in a private placement, according to U.S. securities filings.
從2020年新冠疫情逐漸升高開始,這支COVAXX 疫苗就吸引了一些重量級人士的支持,包含來自創業家彼得戴曼迪斯 (Peter Diamandis,該公司的共同創辦人)以及勵志演說家羅賓斯(Tony Robbins)的背書。根據他們三月向美國證券交易委員會所提交的文件,那時該公司已經私募了13.5億美金。
Prince's involvement in vaccine distribution, which has not been previously reported, sheds new light on the race to profit from the uncertainties of the pandemic. Vaccine supply deals have often been forged through direct government ties to drugmakers, global health organizations or diplomatic channels.
普林斯這段之前不為人知,爭取疫苗銷售權的行動,更讓人看清面對疫情,人心惶惶時,各方爭發疫苗財的真貌。疫苗供應方面的交易,往往取決於製藥廠、世界衛生組織或外交管道,是否能直接與政府打上交道。
Reuters couldn't determine how Prince first became associated with COVAXX, or whether he has brokered any vaccine supply deals.
路透社無法得知普林斯從何時開始與COVAXX掛鉤,或他是否曾經擔任任何疫苗供應交易的掮客。
Prince did not respond to questions for this story. A source close to Prince said that "Erik has been helping a vaccine manufacturer set up distribution," but declined to give details.
普林斯並未回應記者針對以上情節所提出的問題。一位接近普林斯的人士僅說「Erik(普林斯)已經在協助一家疫苗製造商設置銷售管道」但拒絕說明更多細節。
Diane Murphy, a public relations consultant for Vaxxinity Inc, which owns COVAXX, declined to answer questions related to Prince. In a statement to Reuters, she said that the company has "accepted introductions from a variety of private, public and non-profit intermediaries, both formally and informally."
COVAXX 母公司Vaxxinity 公司的公關顧問墨菲(暫譯, Diane Murphy)拒絕回答與普林斯有關的提問。她只在對路透社發表的一張紙上聲明中說,該公司已經「正式或非正式地,與一些來自私人、政府或非營利機構的中間人有了初步的接觸。」
'DOLLARS PER DOSE'
每劑疫苗的佣金
Prince has made headlines for years, first as chief executive of Blackwater, whose security guards fatally shot more than a dozen Iraqi civilians in Baghdad in 2007. After he left Blackwater, Prince pushed to privatize the war in Afghanistan by having contractors fight instead of the U.S. military and became embroiled in an investigation into possible collusion between the Trump election campaign and the Russian government.
普林斯的名字多年來常上報紙頭版,首先是因為2007年他還身為黑水公司總裁時,他私人保鑣在巴格達射死了十多位伊拉克百姓。他離開黑水公司之後,又推動在阿富汗雇用傭兵,來代替美國軍人打仗,後來又捲入川普選舉時的通俄門。
Prince sought to recruit a close associate, the late Paul Behrends, a former Republican congressional staffer and lobbyist who represented Blackwater for over two years, to help in the COVAXX project.
普林斯本想招募已故的親密夥伴布倫茲(暫譯,Paul Behrends)協助COVAXX 計畫,因為布倫茲曾在共和黨眾議院中擔任幕僚,並為黑水公司遊說超過兩年。
In a series of text messages to Behrends, Prince described the potential for profit from selling the vaccines.
普林斯在一系列發給布倫茲的簡訊中,這樣形容銷售該疫苗可獲利的潛力:
"There's room for a couple dollars per dose in commissions," Prince said in a Nov. 9 text to Behrends. He shared with Behrends a "Letter of Authorization" on COVAXX letterhead signed by senior vice president Brandon Schurter as proof of his distribution deal. Schurter did not respond to requests for comment.
普林斯在11月9日寫給布倫茲的簡訊中說:「每劑疫苗的佣金可達2美元」。普林斯還跟布倫茲分享了一封寫在COVAXX官方信箋,並由該公司資深副總舒特(暫譯,Brandon Schurter)簽字的「授權書」,證明他已獲得銷售權。針對以上事件,舒特本人並未回應路透社的提問。
The October 2020 letter said that an entity called Windward Capital, with an address in Abu Dhabi, was authorized to "assist in the process of creating distribution networks." Reuters could not find a Windward Capital registered in Abu Dhabi. But a company called Windward Holdings that handles "professional, scientific and technical activities" is listed there, with Erik Prince the sole named shareholder.
在該封寫於2020年10月的信中,普林斯宣稱已經在阿布扎比成立了一家名為「Windward 資產」的公司,被授權來「協助建立銷售網」。路透社無法在阿布扎比找到一間註冊為「Windward 資產」的公司,但找到了一間名為「Windward 控股」,目標在「處理專業方面、科學方面與技術方面活動」的公司,並且普林斯是該公司唯一掛名的股東。
Prince is also the managing member of a corporate entity called Windward Wyoming LLC, which says it has a "global distribution" deal with COVAXX, according to records of non-public business agreements seen by Reuters. The company was formed in October 2020, public incorporation records in Wyoming show.
普林斯同時也是一家名為「懷俄明州Windward 股份有限公司」的總經理。據路透社所見過,一份非公開的商業協定中說,該公司成立的目標為「在全球銷售COVAXX疫苗」。根據懷俄明州的官方資料,該公司成立於2020年10月。
Lawyers and other officials affiliated with the various Windward entities did not respond to requests for comment.
以上名為Windward的兩間公司,其律師及相關負責人都未回應路透社就以上所發出的提問。
Prince and Behrends were negotiating how to carve up prospective sales territories by country, said Barry Angeline, a friend of Behrends. But their possible collaboration was cut short in December, when Behrends died.
布倫茲的一位朋友安吉林(暫譯,Barry Angeline)說,普林斯和布倫茲曾經協商過,當如何針對不同國家的地區而提高疫苗的銷售量,但此合作之可能性因12月布倫茲過世而告吹。
Vaxxinity consultant Murphy told Reuters the company has a "focus on the developing market" – including the many countries that have been unable to acquire the shots made by global drugmakers and stockpiled by wealthier nations.
Vaxxinity 的顧問墨菲告訴路透社,該公司「專注於開發中國家的市場」— 包含那些無法透過全球製藥廠得到疫苗,或被富有國家囤積,以致無法取得疫苗的國家。
HIGH-PROFILE BACKERS
聲名顯赫的支持者
COVAXX was formed in early 2020 as a subsidiary of United Biomedical Inc (UBI), a maker of diagnostic tests and veterinary vaccines, to address the coronavirus pandemic. In April, the company announced it was being consolidated into a new holding corporation called Vaxxinity.
COVAXX的母公司United Biomedical Inc (UBI)公司,原本是製造檢驗試劑及動物疫苗的,於2020年初期分出子公司COVAXX,以對抗新冠疫情。四月時,該官司宣布被合併進入一家新的控股公司,名為Vaxxinity.
COVAXX's backers were quick to publicize the vaccine's potential beginning in July, based on early tests in animals, and before the first clinical trials in people began in Taiwan.
COVAXX的支持者從七月起,就已經開始大肆宣傳該疫苗的潛力,根據的不過是早期的動物實驗數據,甚至早在以台灣人首次進行臨床人體實驗之前。
Diamandis, who is listed as a co-founder of Vaxxinity, wrote in a July 30 post on his personal blog that the vaccine was safe for patients and likely effective in the elderly. He told Reuters he made it clear in those posts that his assertions were based on previous trial results of other vaccines developed by the company.
列名Vaxxinity共同創辦人的戴曼迪斯,2020年7月30日於自己私人部落格上宣稱,該疫苗不但可供病人安全接種,並且在年長者身上也有效。他告訴路透社說,他在部落格上清楚說明了,那些是根據自己公司「其他」疫苗「過去」實驗的結果而認定的。
A few weeks later, Robbins, the self-help coach, held a webinar promoting COVAXX titled "The most powerful vaccine you've never heard of." Robbins said in the video that he was one of the company owners. "I've invested in the company, so everyone knows. Because I've been blown away by seeing these results," he said.
幾週之後,有「自助教練」之稱的羅賓斯舉辦了一場網路論壇,來宣傳COVAXX,稱其為「你平生未見,最威力強大的疫苗」。羅賓斯在該影片中聲稱自己是該公司所有人之一,還說:「我要在這裡告訴大家,我投資這家公司,因為親眼目睹了施打這疫苗的神效。」
Robbins "remains an investor," his spokeswoman Jennifer Connelly said in a statement to Reuters. She added, "Mr. Robbins is not involved in the management or daily operations."
羅賓斯的女發言人康納莉(暫譯,Jennifer Connelly )在一篇給路透社的聲明中說「羅賓斯直到如今仍然是該公司的一位投資者,但他並未參與該公司日常的運作管理。」
In October, COVAXX and shipping giant Maersk announced a partnership to provide global transport of the vaccine as soon as it becomes available. The Maersk official quoted in the release, Rob Townley, said the company recognized the urgent need to safely deliver COVID-19 vaccines worldwide.
COVAXX 和全球航運巨擘「快桅」公司於十月宣布合夥,將在疫苗上市後,以最快速度供應至全球。「快桅」公司的塔利(暫譯,Rob Townley)並在該聲明中說該公司認知到當務之急乃是將新冠疫苗安全運至全球各地。
Townley was briefly an aide to former U.S. Army general Michael Flynn during Flynn's short tenure as Trump's National Security Adviser. In an interview, Townley said he knows Prince but couldn't discuss Prince's involvement.
塔利曾經在川普總統任命佛林(Michael Flynn)擔任美國國家安全顧問的短短期間,短暫擔任過佛林的幕僚。塔利在一場訪問中說,他認識普林斯,但對普林斯所參與的事務不予置評。
Data on how well the vaccine works is still pending. In an email to Reuters, Vaxxinity’s Murphy said the company had completed the Phase 1 trial of 60 volunteers aged 20 to 55 in Taiwan, and is conducting a new study of 3,800 people there, including teens and elderly participants. The company plans larger trials in Brazil and India later this year.
該疫苗的果效尚有待數據證明。Vaxxinity 的墨菲在發給路透社的一封電子郵件中說,該公司已經結束在台灣針對60名,20-55歲志願者的第一期實驗。現在正在台灣進行為數3800人,包含青少年及年長者的新實驗。今年下半年計畫在巴西和印度展開更大規模的實驗。
Reporting by Aram Roston in Washington and Lisa Barrington in Abu Dhabi; Editing by Michele Gershberg
以上由在華盛頓的Aram Roston,以及在阿布札比的Lisa Barrington報導,由 Michele Gershberg編輯
以上路透社英文原稿連結為
EXCLUSIVE Blackwater founder Prince takes role in COVID vaccine venture | Reuters
被回報 5 次|1 份回應 |1,174 天前
LINE 機器人 查謠言詐騙 ・
台灣實科協會